PeopleBio, Inc. announced that it expects to receive KRW 14.2 billion in funding from iMarketKorea Inc., Ds Investment & Securities Co.,Ltd., Momens Solution Co. Ltd, NH Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd. and another invetsor
July 09, 2024
Share
PeopleBio, Inc. announced a private placement to issue Zero Coupon Series 7 Bearer-Bearing Interest-Bearing, Unsecured Private Placement Convertible Bonds Due July 12, 2027 for the gross proceeds of KRW 10,000,000,000 and Zero Coupon Series 6 Bearer-Bearing Interest-Bearing, Unsecured Private Placement Convertible Bonds due July 12, 2027 for the gross proceeds of KRW 4,200,000,000; aggregate gross proceeds of KRW 14,200,000,000 on July 10, 2024. The transaction will include participation from returning investor iMarketKorea Inc. The transaction has been approved by shareholders, restricted to a hold period and is expected to close on July 12, 2024. The bonds are 100% convertible into 2,631,578 shares at a fixed conversion price of KRW 3,800 from July 12, 2025 to June 12, 2027. The bonds bear zero coupon rate, 2.5% maturity rate and matures on July 12, 2027.
Series 6 bonds - The transaction will include participation from new and returning investors Hanyang Securities Co. Ltd. for KRW 1,400,000,000, Ds Investment & Securities Co.,Ltd. foe KRW 300,000,000, Momens Solution Co. Ltd for KRW 300,000,000,NH Investment & Securities Co., Ltd. ( In the position of trustee of Fund 1 ) for KRW 500,000,000, NH Investment & Securities Co., Ltd. ( In the position of trustee of Fund 2 ) for KRW 270,000,000, NH Investment & Securities Co., Ltd. ( In the position of trustee of Fund 3 ) for KRW 230,000,000, NH Investment & Securities Co., Ltd. ( In the position of trustee of Fund 4 ) for KRW 500,000,000 and Kim Do-wan for KRW 700,000,000. . The transaction has been approved by shareholders, restricted to a hold period and is expected to close on July 12, 2024. The bonds are 100% convertible into 1,105,263 shares at a fixed conversion price of KRW 3,800 from July 12, 2025 to June 12, 2027. The bonds bear zero coupon rate, 2.5% maturity rate and matures on July 12, 2027.
HANYANG SECURITIES CO., Ltd. is a Korea-based company engaged in the financial business. The Company operates securities dealing business, including stocks, bonds, promissory notes, foreign currency securities, futures, options and others; entrust buying and selling business; securities underwriting business, including initial public offering (IPO), stocks, national bonds and public bonds, corporate bonds, foreign currency securities and others; credit offering business; discretionary investment business, and bond transaction with repurchase agreements dealing business.
PeopleBio, Inc. announced that it expects to receive KRW 14.2 billion in funding from iMarketKorea Inc., Ds Investment & Securities Co.,Ltd., Momens Solution Co. Ltd, NH Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd. and another invetsor